Danilo Ricciardi

Danilo Ricciardi

Auto-generated profile, based on publicly available information

Danilo Ricciardi

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands Policlinico Universitario Campus Bio-Medico, Rome, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2019 in EP Europace
Verified
Journal Article
Open access
PDF file
VWVanessa Weberndörfer
Vanessa Weberndörfer
RBRoy Beinart
Roy Beinart
DRDanilo Ricciardi
Danilo Ricciardi
JEJoris Ector
Joris Ector
MMMohanad Mahfoud
Mohanad Mahfoud
MHMartin E.W. Hemels
Martin E.W. Hemels
Atrial fibrillation (AF), is the most common sustained arrhythmia and is associated with a substantial increase in morbidity and mortality. Several studies have demonstrated sex-related differences in various aspects, including age at diagnosis, clinical manifestations, management and prognosis. These dissimilarities may dictate different approaches to management and could translate to differences in outcomes. However, similarly to other cardiovascular therapies, there may be a tendency to treat females more conservatively and less aggressively than male patients. The use of oral anticoagulants, for example, is lower in female patients with AF. Electrical cardioversion is less often used. Likewise, despite higher rates of adverse reactions to antiarrhythmic drugs in women, they are less likely to undergo catheter ablations, a well-established therapeutic approach to symptomatic patients with recurrences of AF. In this article, we review sex related dissimilarities in patients with AF. In addition, we discuss various treatment options, and specifically refer to differences in access of treatment, success rates, and potential treatment-related complications.

1 November 2018 in Indian Heart Journal
Verified
Journal Article
Open access
MZMatteo Ziacchi
Matteo Ziacchi
GZG. Zucchelli
G. Zucchelli
DRD. Ricciardi
D. Ricciardi
GMG. Morani
G. Morani
ERE. De Ruvo
E. De Ruvo
MBM. Biffi
M. Biffi
To evaluate Attain Performa (Medtronic, Dublin, Ireland) quadripolar lead performance in clinical practice and, secondarily, to compare its long term clinical outcomes vs bipolar leads for left ventricular (LV) pacing. We retrospectively analyzed clinical, procedural and follow-up data of 215 patients implanted with a quadripolar lead. One hundred and twenty one patients implanted with bipolar lead were selected to compare long-term clinical outcomes. The quadripolar lead was implanted in the target vein in 196 patients (91%) without acute dislodgements. In 50% of patients the chosen final pacing configuration at implant would not have been available with bipolar leads. A dedicated quadripolar pacing vector was chosen more frequently when the LV tip location was apical than otherwise (65.6% vs 42.7%, p=0.003). After a median follow-up of 14 months, the LV pacing threshold was less than 2.5V at 0.4ms in 98 patients (90%) with a safety margin between phrenic nerve and LV pacing threshold >3V in 97 patients (89%). We observed a slight trend toward a lower risk of heart failure worsening and a lower incidence of ventricular arrhythmias and pulmonary congestion in patients implanted with quadripolar leads compared with the control group. Quadripolar leads improve the management of phrenic nerve stimulation at no trade-off with pacing threshold and lead stability. Quadripolar leads seems to be associated with a lower incidence of VT/VF and pulmonary congestion, when compared with bipolar leads, but further investigations are necessary to confirm that this positive effect is associated with better LV reverse remodeling.

1 March 2018 in EP Europace
Verified
Closed access
DRD Ricciardi
D Ricciardi
GVG Vetta
G Vetta
ANA Nenna
A Nenna
GMG Migliaro
G Migliaro
VCV Calabrese
V Calabrese
GSG Di Sciascio
G Di Sciascio
Background and Objectives: ECG criteria for the diagnosis of left ventricular hypertrophy (LVH) have shown heterogeneity in terms of sensitivity and specificity, the current ECG recommendations count more than 35 LVH criteria. This study tested the predictivity of current major LVH criteria and compared with the recently published Peguero and LoPresti index that demonstrated an improved predictiveness. The authors also analyzed the results with different amplitudes and R-S waves combinations and try to improve the diagnostic value for LVH.

1 May 2013 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
MRMoisés Rodríguez-Mañero
Moisés Rodríguez-Mañero
FBFatih Bayrak
Fatih Bayrak
MNMehdi Namdar
Mehdi Namdar
RARuben Casado Arroyo
Ruben Casado Arroyo
DRDanilo Ricciardi
Danilo Ricciardi
PBPedro Brugada
Pedro Brugada
We present the case of a 50-year-old patient with several episodes of syncope and documented simultaneous wide and narrow QRS complex tachycardia. We then review this tacharrhythmia, focusing on electrophysiological findings and pathophysiology, diagnosis and treatment.